Web Results

Bortezomib - Wikipedia

en.wikipedia.org/wiki/Bortezomib

Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. Proteasomes are cellular complexes that break down proteins. In some cancers ...

VELCADE® (bortezomib) Official Website

www.velcade.com/

The Official Website for VELCADE® (bortezomib). ... VELCADE (bortezomib) is approved for the treatment of people with multiple myeloma (a cancer of the ...

Bortezomib - Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/bortezomib.aspx

(bore TEZ oh mib). Trade name: Velcade<sup>®</sup>. Chemocare.com uses generic names in all descriptions of drugs. Velcade is the trade name for Bortezomib. In some ...

Bortezomib - DrugBank

www.drugbank.ca/drugs/DB00188

The boron atom within bortezomib catalytically binds the active site of the 26S proteasome with high affinity and specificity, thereby resulting in cell cycle arrest  ...

Velcade (bortezomib) dosing, indications, interactions, adverse ...

reference.medscape.com/drug/velcade-bortezomib-342256

Medscape - Indication-specific dosing for Velcade (bortezomib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

Bortezomib (Velcade) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/bortezomib

Feb 12, 2014 ... The biological therapy drug bortezomib (Velcade) is a treatment for myeloma. The possible side effects include feeling or being sick; tiredness; ...

Drug Safety and Availability > Velcade (bortezomib) Information

www.fda.gov/Drugs/DrugSafety/ucm106494.htm

Jul 9, 2015 ... The Food and Drug Administration has approved Velcade to treat a type of cancer called multiple myeloma. Velcade should only be used in ...

Bortezomib: MedlinePlus Drug Information

medlineplus.gov/druginfo/meds/a607007.html

May 1, 2010 ... Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least ...

Bortezomib as the First Proteasome Inhibitor Anticancer Drug - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3306611/

Bortezomib (Velcade, Millennium Pharmaceuticals, Inc., Cambridge, MA, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ) ...

387447 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/Bortezomib

Bortezomib is a dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that  ...

More Info

Bortezomib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com

Easy to read patient leaflet for bortezomib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Definition of bortezomib - NCI Drug Dictionary - National Cancer ...

www.cancer.gov

Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins. By blocking the targeted proteolysis normally ...

Velcade (Bortezomib): Side Effects, Interactions, Warning, Dosage ...

www.rxlist.com

Oct 9, 2015 ... VELCADE® for Injection contains bortezomib which is an antineoplastic agent. Bortezomib is a modified dipeptidyl boronic acid. The chemical ...